Pessary Clinical Outcomes — Real Success Rates, Discontinuation, and Satisfaction Data (2026)
Pessary Clinical Outcomes — What the Data Actually Shows
Headline outcome numbers
60-85%
Successful initial fitting rate
By POP stage. Higher for Stage I-II, lower for Stage III-IV.
~78%
12-month continuation rate
Patients still using pessary at 1 year post-fit.
~1-3%
Serious complication rate at 5+ years
Erosion, embedded pessary, urinary retention.
~85%
Patient satisfaction
Reported "satisfied" or "very satisfied" at 12 months.
Success rates by POP-Q stage
The strongest single predictor of a successful pessary fitting is the stage of prolapse. Later-stage prolapse has more complex anatomy that is harder to support with a ring:
| POP-Q stage | Successful initial fitting | 12-month continuation | Best pessary type |
|---|---|---|---|
| Stage I | 85-90% | ~80% | Ring (with or without support) |
| Stage II | 75-85% | ~78% | Ring (most common indication) |
| Stage III | 60-70% | ~65% | Ring with support, larger size, or Gellhorn |
| Stage IV | 30-40% | ~50% (of those fit) | Gellhorn typically; some Stage IV cases surgery-first |
Silicone vs PVC — the 2024 head-to-head data
A 2024 randomized controlled trial published in the International Urogynecology Journal directly compared silicone and PVC ring pessaries. Silicone won on the outcomes that matter most for long-term use:
| Outcome measure | Silicone (SciMed-equivalent) | PVC (older/generic) |
|---|---|---|
| Successful self-management at 12 months | Significantly higher | Lower |
| Vaginal discharge complaints | Fewer | More frequent |
| Odor complaints | Fewer | More frequent |
| Comfort during long-term wear | Preferred by patients | Less preferred |
| Overall patient preference for continuation | Higher | Lower |
Patient self-management outcomes — the TOPSY findings
Historically, pessaries were removed and cleaned in clinic every few months. The 2024 TOPSY randomised controlled trial specifically evaluated whether patients could safely manage their own devices at home. The findings:
- Patient self-management is non-inferior to clinic-based care for both safety and satisfaction outcomes
- Structured training at fitting is important — patients who received hands-on training on removal/reinsertion had better outcomes
- Recommended cadence for self-managers: weekly removal + cleaning is safe. Some patients successfully clean less often (monthly, quarterly) with lower BV/yeast risk.
- Provider follow-up remains important even for self-managers — typical schedule is 2 weeks post-fit, 3 months, then every 6-12 months
Discontinuation reasons — why patients stop using pessaries
Of the ~20-25% of patients who discontinue their pessary within the first year, the reasons cluster into a few categories:
| Reason for discontinuation | Approximate share | Preventable? |
|---|---|---|
| Pessary keeps falling out | ~35% of discontinuations | Often — usually solved by larger size or with-support variant |
| Discomfort or awareness of device | ~25% | Often — usually solved by smaller size or re-fit |
| Recurrent BV or yeast | ~15% | Often — topical vaginal estrogen dramatically reduces recurrence |
| Chose surgery instead | ~15% | Not preventable — patient preference |
| Erosion or bleeding | ~5% | Mostly preventable with follow-up + topical estrogen |
| Other | ~5% | Varies |
Practical implication: most discontinuations are addressable with a size change, adding topical vaginal estrogen, or switching between with-support / without-support ring. Try a re-fit before giving up on pessary treatment entirely.
Long-term safety data — the 5+ year window
Silicone ring pessaries have been in clinical use since roughly the 1950s. Long-term complication rates at 5+ years of continuous use:
| Complication | Rate at 5+ years | Almost always preventable by |
|---|---|---|
| Vaginal wall erosion | 1-3% | Regular follow-up + topical vaginal estrogen for post-menopausal patients |
| Embedded pessary | <1% | Follow removal + cleaning schedule prescribed by provider |
| Urinary retention (from too-large fit) | 1-3% at initial fitting only | Correct size selection |
| Fistula (very rare) | <0.1% | Regular follow-up |
| Cancer risk | None documented | Silicone is chemically inert |
Patient-reported satisfaction — what patients actually say
Across published studies, patient satisfaction with silicone ring pessaries is consistently high in appropriately-selected patients:
- ~85% report "satisfied" or "very satisfied" at 12 months
- ~90% would recommend the pessary to a friend with similar symptoms
- ~75% report meaningful reduction in prolapse symptoms within the first 4 weeks
- ~70% of continuers report improved quality of life — particularly on measures like ability to exercise, sleep quality, and confidence during daily activities
Satisfaction is highest among:
- Post-menopausal women on topical vaginal estrogen (adds ~10-15% to satisfaction)
- Patients receiving structured self-management training
- Patients who chose pessary as a first-line trial rather than being pushed to it after surgical failure
Cost-effectiveness data
The 2024 TOPSY trial specifically evaluated cost-effectiveness of pessary care vs comparator management. Findings:
- Patient self-management is not only clinically non-inferior to clinic-based care but also meaningfully more cost-effective — reduces clinic visit burden by roughly 50-70%.
- Silicone pessary at $49.99 direct vs traditional distributor pricing of $80-150 = significant savings for both patient and healthcare system.
- Compared to surgical repair ($8,000-$25,000 out-of-pocket + weeks of recovery), a pessary trial is essentially free by comparison. See our pessary vs surgery decision guide.
Who benefits most — the strongest predictors of success
Across the published data, patients most likely to have a successful, satisfied long-term experience with a silicone pessary share these characteristics:
- Stage I-III prolapse (rather than Stage IV)
- Willing to attend follow-up appointments — the single strongest predictor of avoiding complications
- Willing to attempt self-management (weekly removal + cleaning) — improves satisfaction
- Adequate vaginal tissue estrogen support — either endogenous (pre-menopause) or via topical vaginal estrogen (post-menopause)
- No unresolved active infection or unexplained bleeding at time of fitting
- Reasonable size match — many first fits work well with sizes 3, 4, or 5
Frequently asked questions
What percentage of women with prolapse actually try a pessary?
Only about 15-20% of women with diagnosed symptomatic POP currently try a pessary first-line, despite ACOG PB 214 recommending it. The gap is largely due to provider workflow (surgery is often the default recommendation) rather than pessary failure. This is why patient-advocacy content matters — see our guide on talking to your doctor.
How does silicone compare to the older rubber pessaries?
Silicone (used since the 1980s) is a dramatic improvement over rubber pessaries (last century's standard). Silicone is: chemically inert, latex-free, does not retain odor, more comfortable against sensitized tissue, and autoclavable. Rubber pessaries are no longer recommended and are essentially not used clinically in the US today.
What about the newer disposable pessaries?
Fem Therapeutics launched a disposable pessary in 2026 at ~$400/year. From an outcome standpoint, single-use disposables have thinner published evidence base than reusable silicone. From a cost standpoint, disposable is 8-16x more expensive over 5 years than SciMed direct at $49.99. See our full reusable vs disposable analysis.
What is the outcome expectation for Gellhorn pessary?
Gellhorn pessaries (space-filling design with a stem) are used for Stage 3-4 prolapse where a ring will not hold. Success rates are lower than ring pessaries because Stage 3-4 cases are more complex. SciMed's silicone Gellhorn is in development for Q1 2027 — join the waitlist if this is your case.